These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 36472472)
41. Therapeutic Antibodies in Cancer Treatment in the UK. Eltarhoni K; Kamel F; Ihebunezie K; Nisar P; Soloviev M Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498915 [TBL] [Abstract][Full Text] [Related]
42. Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections. Dichtl S; Zaderer V; Kozubowski V; Abd El Halim H; Lafon E; Lanser L; Weiss G; Lass-Flörl C; Wilflingseder D; Posch W Front Med (Lausanne); 2022; 9():1005589. PubMed ID: 36250084 [TBL] [Abstract][Full Text] [Related]
43. Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study. Gazzah A; Bedard PL; Hierro C; Kang YK; Abdul Razak A; Ryu MH; Demers B; Fagniez N; Henry C; Hospitel M; Soria JC; Tabernero J Ann Oncol; 2022 Apr; 33(4):416-425. PubMed ID: 35026412 [TBL] [Abstract][Full Text] [Related]
44. The global landscape of approved antibody therapies. Lyu X; Zhao Q; Hui J; Wang T; Lin M; Wang K; Zhang J; Shentu J; Dalby PA; Zhang H; Liu B Antib Ther; 2022 Oct; 5(4):233-257. PubMed ID: 36213257 [TBL] [Abstract][Full Text] [Related]
45. Metrics for antibody therapeutics development. Reichert JM MAbs; 2010; 2(6):695-700. PubMed ID: 20930555 [TBL] [Abstract][Full Text] [Related]
46. Cancer therapy with bispecific antibodies: Clinical experience. Thakur A; Lum LG Curr Opin Mol Ther; 2010 Jun; 12(3):340-9. PubMed ID: 20521223 [TBL] [Abstract][Full Text] [Related]
58. Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC). Parums DV Med Sci Monit; 2021 Sep; 27():e934854. PubMed ID: 34565792 [TBL] [Abstract][Full Text] [Related]
59. Bispecific antibodies for the treatment of lymphomas: Promises and challenges. Schuster SJ Hematol Oncol; 2021 Jun; 39 Suppl 1():113-116. PubMed ID: 34105818 [TBL] [Abstract][Full Text] [Related]
60. Generation of bispecific antibodies using chemical conjugation methods. Dimasi N; Kumar A; Gao C Drug Discov Today Technol; 2021 Dec; 40():13-24. PubMed ID: 34916015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]